INTRODUCTION
Transforming growth factor fl1 (TGF/,1) is one of a family of related polypeptide mediators consisting of five isoforms, three of which have been identified in mammals. The TGF,fs are pluripotent mediators, having amongst their many functions the ability to modulate cell growth and stimulate the production and deposition of connective tissue matrix components including collagens, fibronectin and proteoglycans. Altered expression of TGF,fs has been implicated in a number of diseases. Increased expression has been observed in fibrotic disorders of the lung [1] [2] [3] , skin [4] , kidney [5] and liver [6] . It has also been suggested that loss of TGFfl expression in the skin and skin tumours is associated with hyperproliferation and a high risk of malignancy [7] . It is therefore important to understand the mechanisms by which TGF,fs mediate their biological effects.
The effect of TGF/31 on collagen deposition culminates from a network of interlinked actions. It increases procollagen synthesis via an increase in mRNA [8] [9] [10] and decreases the proportion of newly synthesized procollagen degraded intracellularly [11] .
TGF#,1 also maximizes its stimulation of collagen deposition by stimulating production of anticollagenases and decreasing the production of collagenase [12] [13] [14] . The effect of TGF1l on collagen synthesis is known to involve binding of transcription factors to elements in the promoter regions of procollagen genes, resulting in upregulation of gene transcription [15] [16] [17] . However, the receptor and signal transduction pathways which lead to these effects are poorly understood.
There for TGF,/% (for review see [18] ). The type I and II receptors have been cloned and these as well as the type V receptor have been found to contain transmembrane serine/threonine kinase signalling motifs [19-221. However, the type I receptor also contains regions with sequence similarity for tyrosine kinase and protein kinase C activation [22] . The type III receptor has also been cloned and its product is a membrane-anchored proteoglycan with no obvious signalling motif [23, 24] . There is co-operativity between the type I and II and the type II and III receptors, with formation of heteromeric complexes [25] [26] [27] [28] . Type I and II receptors have been shown to be involved in all effects of TGF,81
that have been investigated [25, [29] [30] [31] [32] . The signalling motifs and functions of the other TGF,/1 receptors/binding proteins have still to be determined and little is known of the intracellular signal transduction pathways. G-proteins act as membrane bound intermediates between cell surface receptors and intracellular effector systems (for review see [33, 34] ). G-proteins are heterotrimers consisting of a-, ,-and y-subunits. They are cyclically regulated, activation occurs by binding of GTP to the a-subunit which is hydrolysed to GDP and P1 resulting in deactivation followed by dissociation of GDP prior to binding more GTP. The involvement of G-proteins in transduction pathways and identification of their a-subunits is aided by the ability of certain bacterial exotoxins to specifically ADP-ribosylate particular a-subunits and inhibit their activity.
Pertussis toxin inhibits ai-subunits which have a broad cellular distribution and ao-subunits which appear to predominate in neuronal cells. In actions of TGF/31, including c-sis mRNA expression and mitogenesis in fibroblasts as well as inhibition of epithelial cell proliferation and chemotaxis of interleukin-2-activated natural killer cells, are mediated through receptors coupled to G-proteins [35] [36] [37] [38] [39] . Giac1, Go and Gs have been implicated in some of these actions [38, 39] . In this study we have begun to investigate the mechanism by which TGF/31 modulates procoflagen production by determining the effects of pertussis toxin on TGF/ll-induced fibroblast procollagen metabolism.
MATERIALS AND METHODS Cell Culture
Human fetal lung fibroblasts (HFL-1) and fetal rat fibroblasts (Rat 2), both obtained from the American Type Culture Collection, (Rockville, MD, U.S.A.) were cultured in 2.4 cm diameter plates with Dulbecco's modified Eagle's medium + 5 % newborncalf serum (NCS) in a humidified atmosphere of air containing 10% CO2 at 37 'C. When cells appeared confluent they were incubated for a further 24 h. The media was then removed and replaced with 1 ml of pre-incubation medium, which contained 4 mM glutamine, 50 ,ug/ml ascorbic acid, 0.2 mM proline and 20% (v/v) NCS and incubated for 24 h. The media were then replaced with 1 ml of fresh preincubation medium containing pertussis toxin (Calbiochem Novabiochem, Nottingham, U.K.) at concentrations between 0 and 500 ng/ml, or indomethacin (Sigma Chemical Co. Ltd., Poole, Dorset, U.K.) at a concentration of 1 ,ug/ml, and incubated for 3 h. Finally the media were replaced with media containing appropriate concentrations of pertussis toxin, indomethacin and porcine TGF,/1 (British Biotechnology, Oxford, U.K.) at concentrations between 0.1 and 10 ng/ml (4-400 pM) and incubated for between 2 and 24 h before harvesting.
Sample preparation
For cultures in which procollagen metabolism was to be assessed, the cell layer was scraped into the medium and aspirated. Each well was washed with 1 ml of PBS and the washings were combined with the initial aspirate. Proteins were precipitated by addition of ethanol to give a final concentration of 67 % (v/v) and left at 4 'C overnight. The precipitated proteins were extracted by vacuum filtration onto polyvinylidene difluoride filters (Millipore, Durapore 0.45 ,tm) and the ethanol-soluble material in the filtrate retained. The filtrate was evaporated to dryness using a Dri-Block Sample Concentrator (Techne DB-3, SC-3). The dried filtrates and the proteins adhering to the filters were hydrolysed in 2 ml of 6 M hydrochloric acid at 110 'C overnight. Hydrolysates were mixed with approximately 70 mg of charcoal and filtered (Millipore, 0.65 ,um) prior to chromatography.
Similar cultures were set up to assess prostaglandin E2 (PGE2) production and cell number by measurement of DNA. At the end of incubation the medium was removed and stored at -40 'C prior to measurement of PGE2. The cell layer was scraped into 1 ml of PBS, aspirated into a microcentrifuge tube and centrifuged at 9000 g for 5 min; the clear supernatant was discarded. Any remaining cells were washed from the well with a further 1 ml of PBS, aspirated and combined with the initial cell pellet. After centrifugation the supernatant was discarded and the pellet was stored at -40 'C prior to analysis of DNA. PGE2 was measured in 10 and 50,1 aliquots of the cellconditioned medium using a specific enzyme immunoassay were expressed as pg per well. DNA was measured using a modified diphenylamine method as described previously [11] .
Measurement of hydroxyproline and calculation of procollagen synthesis and the proportion degraded Hydroxyproline was isolated and measured by reverse-phase HPLC of 7-chloro-4-nitrobenzo-2-oxa-1 ,3-diazole (NBD-Cl)-derivatized hydrolysates as described previously [11, 40] . Hydroxyproline content was determined by comparing peak areas of samples from the chromatogram with those generated from standard solutions, derivatized and separated under similar conditions and run on the same day. As the cell monolayer contains a small amount of procollagen and the serum contained hydroxyproline, the amount of hydroxyproline present in the combined culture medium and cell layer at the start of incubation was determined in both the ethanol-soluble and -insoluble fractions. This background level, which represented between 1.95 and 2.62 nmol hydroxyproline per well in the insoluble fraction and between 0.92 and 1.87 nmol hydroxyproline per well in the soluble fraction, was then subtracted from the sample values. This represented between 15 and 22 % ofthe total hydroxyproline measured in each sample after a 24 h incubation. The hydroxyproline present in the ethanol-soluble fraction, containing free amino acids and small peptides, from each culture was taken to represent hydroxyproline derived from the degradation of procollagen during the culture period, whilst the hydroxyproline in the ethanol-insoluble fraction was taken to represent hydroxyproline in intact procollagen and was called procollagen production. The proportion of procollagen degraded can be calculated by dividing the hydroxyproline content of the ethanol-soluble fraction by the sum of the hydroxyproline in the ethanol-soluble and -insoluble fractions. The rate of synthesis was obtained from the combined values for ethanol-soluble and -insoluble fractions, and rates of degradation and production were obtained from values for ethanol-soluble and -insoluble fractions respectively and expressed per ,ug DNA per hour.
Statistical analysis
Statistical evaluation was performed using an unpaired t-test or by one-way analysis of variance for multiple comparisons using the Newman-Keuls procedure. The mean values of various parameters were said to be significantly different when the probability of the differences of that magnitude, assuming the null hypothesis to be correct, fell below 5 % (i.e. P < 0.05).
Where mean values are calculated, standard errors of the mean (S.E.M.) are also given. Figure 1 shows the effect of TGF,/1 on fibroblast procollagen metabolism. Production and synthesis increased in a dose-related manner with maximal stimulation obtained at 0.5 ng/ml which remained constant up to 10 ng/ml. The proportion ofprocollagen degraded intracellularly decreased from 22 .80 + 0.69 % in control cultures to 19.28 + 0.79 % in cultures with 1 ng/ml TGF,/1 (P < 0.01). All further studies were carried out with TGF/31 at a concentration of 1 ng/ml.
RESULTS
The effect of pertussis toxin, at concentrations of 10, 100 and 500 ng/ml, on fibroblast procollagen production is shown in appeared normal microscopically, and procollagen production was not affected, but at 500 ng/ml some cells lost their characteristic spindle shape and became rounded, a small decrease in procollagen production was also observed. In the presence of TGF/?1 and pertussis toxin, procollagen production was increased. 10 .91 + 0.51 pmol hydroxyproline per ,ug DNA per hour in the presence of TGF,81 and 100 ng/ml pertussis toxin (P < 0.01). Figure 3 shows the effects of pertussis toxin (100 ng/ml) and the cyclooxygenase (prostaglandin endoperoxide synthase) inhibitor, indomethacin, on fibroblast procollagen production. Indomethacin (1 ug/ml) increased procollagen production by 20% from 34 Figure 4 Effect of TGFfi1, pertussis toxin and Indomethacin on human tetal lung flbroblast PGE2 production PGE2 was measured in the culture medium 24 h after addition of TGFf61 (1 ng/ml), pertussis toxin (100 ng/ml) and indomethacin (1 4g/ml) in the combinations indicated. Each value represents the mean + S.E.M. for five replicate cultures.
The effect of TGFfi1 on PGE2 production by human fetal lung fibroblasts is shown in Figure 4 . Control cultures contained 239 + 90 pg of PGE2 per well. In the presence of TGF/J1 the PGE2 production increased about 5-fold to 1175+291 pg per well (P < 0.01). Pertussis toxin and indomethacin alone showed a tendency to decrease basal PGE2 production but this was not significant. However, pertussis toxin and indomethacin completely blocked the TGF/l-induced increase in PGE2 (P < 0.01 in both cases). Figure 5 shows the changes in PGE2 (Figure 5a ) and procollagen production ( Figure Sb) procollagen synthesis and its potentiation by pertussis toxin, experiments were performed in the presence of indomethacin, and fibroblast PGE2 production was measured. Indomethacin alone stimulated procollagen synthesis, indicating that the cells synthesized prostaglandins under basal culture conditions. In the presence of TGF,81, indomethacin also potentiated the increase in procollagen synthesis and production to a similar extent to that induced by pertussis toxin. The effects of pertussis toxin and indomethacin on TGF/Jl-induced procollagen production and synthesis were not additive, suggesting that both agents were acting on the same pathway. TGF,/3 increased PGE2 production and this increase was blocked by pertussis toxin and indomethacin. These results suggest that the potentiation of TGF,/1-stimulated procollagen synthesis and production by pertussis toxin is due to inhibition of TGF/ll-induced PGE2 synthesis and further suggests that TGF,l1-induced fibroblast production of prostaglandins is mediated either directly or indirectly through a pertussis toxin-sensitive G-protein. PGE2 is also a potent inhibitor of fibroblast proliferation [48] and may be at least partly responsible for TGF,J-induced inhibition of cell proliferation observed in many cells. PGEs have previously been shown to inhibit procollagen synthesis and increase the proportion of newly synthesized procollagen degraded intracellularly by human lung fibroblasts [42,44 46] . In the present studies TGF/?1 induced PGE2 production, which had an inhibitory effect on procollagen synthesis but did not affect the proportion of procollagen degraded intracellularly. This difference may be explained by the amount of PGE2 produced by the fibroblasts which resulted in concentrations of about 1-2 ng/ml in the media of cells incubated with TGF/.1. Previous studies have shown effects of exogenously applied PGE2 on procollagen synthesis at concentrations in the range of 10-250 ng/ml [44 46 ], whereas effects on degradation appear to require concentrations of at least 2 zg/ml [42, 44] .
In this study we have also shown that the effects of TGF,81 on PGE2 production precede the increase in procollagen production.
PGE2 production was increased within 4 h of addition of TGFf1 but stimulation of procollagen production was not apparent until 16 h. To our knowledge this is the first report of the timecourse of TGFfll-induced procollagen production. However, procollagen mRNA levels have been reported to be increased in as little as 2 h following treatment of rat kidney fibroblasts with TGF,81 [9] . This apparent discrepancy in the time-course of changes in mRNA and protein synthesis could be explained either by differences in cell type or by the increase in PGE2 production, which may negate the effect of increased procollagen mRNA on procollagen synthesis at the early times.
The receptor(s) mediating these effects of TGF,81 is(are) uncertain, although it is likely that receptors I and II are involved. TGF,l1-mediated effects on cell proliferation have previously been attributed to the type I receptor [49] and these effects were shown to be coupled through pertussis toxin-sensitive G-proteins [37] . However, studies demonstrating the cooperative nature of the TGF,/ type I and II receptors [25] suggest that the antiproliferative effects of TGFfl, are mediated through the type II receptor in conjunction with the type I receptor [30] . Both type I and type II receptors have been shown to contain cytoplasmic serine/threonine kinase signalling motifs and the type II receptor has been shown to require its kinase activity to enable signalling of growth inhibition [25] . However, it is known that receptors may be coupled to multiple signalling motifs which enable a diverse range of responses to receptor activation, and it has been reported that a consensus G-protein activating sequence has been found in the type II receptor (Arg356-Lys381) but this has yet that the multifunctional nature of responses to TGF,81 may be due to different isoforms of receptor I [29, 31, 32] . Whether TGF,/J-induced prostaglandin and procollagen synthesis are mediated through one of these receptors or another of the less well characterized TGF, receptors/binding proteins remains to be determined.
These results demonstrate that the effects of TGF,81 on fibroblast procollagen metabolism are modulated by production of PGE2 which is inhibited by pertussis toxin or indomethacin with a concomitant increase in procollagen synthesis. From these data we conclude that the effects of TGF,/1 on PGE2 but not procollagen synthesis are mediated via a receptor linked, directly or indirectly, to a pertussis toxin-sensitive G-protein.
